Drug Type Antibody drug conjugate (ADC) |
Synonyms anti-CD64 antibody-drug conjugate(Tokyo Medical and Dental University/Kyowa Hakko Kirin) |
Target |
Action antagonists |
Mechanism CD64 antagonists(High affinity immunoglobulin gamma Fc receptor I antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Autoimmune Diseases | Preclinical | Japan | - | |
Chronic Myelomonocytic Leukemia | Preclinical | Japan | - | |
Inflammation | Preclinical | Japan | - | |
Solid tumor | Preclinical | Japan | - |